| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Möhler H | |
| P433 | issue | 2 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 505-516 | |
| P577 | publication date | 2006-08-26 | |
| P1433 | published in | Cell and Tissue Research | Q1524113 |
| P1476 | title | GABA(A) receptor diversity and pharmacology | |
| P478 | volume | 326 |
| Q26783428 | 1p36 deletion syndrome: an update |
| Q30698264 | A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra |
| Q37003433 | A novel, rapid, inhibitory effect of insulin on alpha1beta2gamma2s gamma-aminobutyric acid type A receptors |
| Q24644809 | Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond |
| Q54973819 | Activation of GABAA Receptors in Colon Epithelium Exacerbates Acute Colitis. |
| Q37523445 | Allosteric modulation of GABAA receptors by extracellular ATP. |
| Q37418303 | Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects |
| Q30495530 | Amygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice |
| Q39389234 | Anticonvulsive Activity in Audiogenic DBA/2 Mice of 1,4-Benzodiazepines and 1,5-Benzodiazepines with Different Activities at Cerebellar Granule Cell GABAA Receptors |
| Q34111492 | Association of the GABRD gene and childhood-onset mood disorders |
| Q38092169 | Benzodiazepine receptor ligands: a patent review (2006-2012). |
| Q42807864 | Bioactivity-Guided Isolation of GABAA Receptor Modulating Constituents from the Rhizomes of Actaea racemosa |
| Q36226150 | Characterizing sleep disorders of adults with tuberous sclerosis complex: a questionnaire-based study and review |
| Q55265914 | Chloride Homeostasis in Neurons With Special Emphasis on the Olivocerebellar System: Differential Roles for Transporters and Channels. |
| Q36417984 | Clinical pharmacology in sleep medicine |
| Q36166925 | Comparison of cell expression formats for the characterization of GABA(A) channels using a microfluidic patch clamp system |
| Q37132185 | Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys |
| Q30400747 | Cortical Synaptic Inhibition Declines during Auditory Learning |
| Q38782368 | Cortisol and DHEA in development and psychopathology |
| Q37755884 | Determinants of the induction of cortical plasticity by non-invasive brain stimulation in healthy subjects |
| Q35115046 | Developmental Expression Patterns of GABAA Receptor Subunits in Layer 3 and 5 Pyramidal Cells of Monkey Prefrontal Cortex |
| Q30482920 | Developmental hearing loss disrupts synaptic inhibition: implications for auditory processing |
| Q38261787 | Developmental pharmacology of benzodiazepines under normal and pathological conditions. |
| Q30464095 | Developmental plasticity of auditory cortical inhibitory synapses |
| Q91863089 | Diazepam and ethanol differently modulate neuronal activity in organotypic cortical cultures |
| Q43756240 | Diazepam treatment blocks the elevation of hippocampal activity and the accelerated proliferation of hippocampal neural stem cells after focal cerebral ischemia in mice |
| Q35970978 | Different transmitter transients underlie presynaptic cell type specificity of GABAA,slow and GABAA,fast. |
| Q28257245 | Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia |
| Q50663402 | Differential effects of etifoxine on anxiety-like behaviour and convulsions in BALB/cByJ and C57BL/6J mice: Any relation to overexpression of central GABAA receptor beta2 subunits? |
| Q41965748 | Differential effects of the dual orexin receptor antagonist almorexant and the GABA(A)-α1 receptor modulator zolpidem, alone or combined with ethanol, on motor performance in the rat. |
| Q30355018 | Differential maturation of vesicular glutamate and GABA transporter expression in the mouse auditory forebrain during the first weeks of hearing |
| Q42679282 | Direct binding of GABAA receptor β2 and β3 subunits to gephyrin. |
| Q38974696 | Discriminative Stimulus Effects of Abused Inhalants |
| Q37939671 | Drug-induced sleep: theoretical and practical considerations |
| Q37411777 | Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators. |
| Q47744146 | Early growth response 1 (Egr-1) directly regulates GABAA receptor α2, α4, and θ subunits in the hippocampus |
| Q36729857 | Early postnatal switch in GABAA receptor α-subunits in the reticular thalamic nucleus |
| Q53712397 | Effect of nitric oxide synthase inhibitors on benzodiazepine withdrawal in mice and rats. |
| Q34347573 | Effects of anesthetics, sedatives, and opioids on ventilatory control |
| Q42872468 | Effects of sildenafil treatment on the development of tolerance to diazepam-induced motor impairment and sedation in mice |
| Q39121651 | Effects of the Selective α5-GABAAR Antagonist S44819 on Excitability in the Human Brain: A TMS-EMG and TMS-EEG Phase I Study. |
| Q34434222 | Engineering a light-regulated GABAA receptor for optical control of neural inhibition. |
| Q34286866 | Enzymatic synthesis of valerena-4,7(11)-diene by a unique sesquiterpene synthase from the valerian plant (Valeriana officinalis). |
| Q52716238 | Expression of the eight GABAA receptor α subunits in the developing zebrafish central nervous system. |
| Q38257354 | Extraction of total RNA in the developing chicken forebrain |
| Q27316919 | Fgfr1 inactivation in the mouse telencephalon results in impaired maturation of interneurons expressing parvalbumin |
| Q42408136 | Flavonoid Myricetin Modulates GABA(A) Receptor Activity through Activation of Ca(2+) Channels and CaMK-II Pathway. |
| Q37600250 | Function and modulation of delta-containing GABA(A) receptors |
| Q24599057 | GABA A receptors: subtypes provide diversity of function and pharmacology |
| Q57165010 | GABA beyond the synapse: defining the subtype-specific pharmacodynamics of non-synaptic GABA receptors |
| Q37115526 | GABA effects during neuronal differentiation of stem cells. |
| Q37929602 | GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia |
| Q24642711 | GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia |
| Q48228150 | GABA receptors make teens resistant to input |
| Q35770888 | GABA system dysfunction in autism and related disorders: from synapse to symptoms |
| Q48153790 | GABA transporters regulate tonic and synaptic GABAA receptor-mediated currents in the suprachiasmatic nucleus neurons. |
| Q37965230 | GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam |
| Q37104140 | GABA(A) receptors in normal development and seizures: friends or foes? |
| Q34915646 | GABA-A receptor-dependent mechanisms prevent excessive spine elimination during postnatal maturation of the mouse cortex in vivo |
| Q57635541 | GABAA receptor subunit specificity: a tonic for the excited brain |
| Q46288122 | GABAA receptor subunits in the human amygdala and hippocampus: Immunohistochemical distribution of 7 subunits. |
| Q39917688 | GABAA receptors containing gamma1 subunits contribute to inhibitory transmission in the central amygdala |
| Q41370905 | GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies |
| Q40569952 | GABAergic modulation with classical benzodiazepines prevent stress-induced neuro-immune dysregulation and behavioral alterations |
| Q30440282 | GABAergic synapses: their plasticity and role in sensory cortex |
| Q37344996 | Gamma-aminobutyric acid-mediated neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia. |
| Q33306146 | Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response |
| Q39884127 | Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes. |
| Q30484579 | Hearing loss alters the subcellular distribution of presynaptic GAD and postsynaptic GABAA receptors in the auditory cortex |
| Q30491091 | Hearing loss prevents the maturation of GABAergic transmission in the auditory cortex |
| Q34659812 | Highly potent modulation of GABA(A) receptors by valerenic acid derivatives |
| Q34073903 | How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. |
| Q35765941 | Human locus coeruleus neurons express the GABA(A) receptor gamma2 subunit gene and produce benzodiazepine binding |
| Q41881713 | In response to: Midazolam-induced acute dystonia reversed by diazepam |
| Q35160645 | Inhibitory synapse formation in a co-culture model incorporating GABAergic medium spiny neurons and HEK293 cells stably expressing GABAA receptors. |
| Q37783378 | Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry |
| Q38197769 | Interneuronal GABAA receptors inside and outside of synapses |
| Q89619699 | Lack of Neurosteroid Selectivity at δ vs. γ2-Containing GABAA Receptors in Dentate Granule Neurons |
| Q30499642 | Lamina-Specific Alterations in Cortical GABAA Receptor Subunit Expression in Schizophrenia |
| Q30430932 | Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus |
| Q42258185 | Midazolam-induced acute dystonia reversed by diazepam |
| Q35134568 | MmTX1 and MmTX2 from coral snake venom potently modulate GABAA receptor activity |
| Q36774209 | Molecular regulation of cognitive functions and developmental plasticity: impact of GABAA receptors |
| Q28235994 | Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents |
| Q39338625 | Neurobiological mechanisms of state-dependent learning. |
| Q42380034 | Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance |
| Q30467276 | Neurosteroid influences on sensitivity to ethanol |
| Q36179239 | Neurotransmission plays contrasting roles in the maturation of inhibitory synapses on axons and dendrites of retinal bipolar cells |
| Q92704398 | Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles |
| Q38166975 | PET radioligands targeting the brain GABAA /benzodiazepine receptor complex |
| Q35100248 | Pathway based analysis of genotypes in relation to alcohol dependence |
| Q34974212 | Phasic and Tonic Inhibition are Maintained Respectively by CaMKII and PKA in the Rat Visual Cortex |
| Q34975644 | Phasic and tonic type A γ-Aminobutryic acid receptor mediated effect of Withania somnifera on mice hippocampal CA1 pyramidal Neurons |
| Q91967823 | Plus ça change? Benzodiazepine prescription in older patients with schizophrenia is common but best avoided |
| Q44082605 | Postsynaptic action of GABA in modulating sensory transmission in co-cultures of rat carotid body via GABA(A) receptors |
| Q47154193 | Potentiating effect of glabridin from Glycyrrhiza glabra on GABAA receptors |
| Q37559568 | Potentiation of decursinol angelate on pentobarbital-induced sleeping behaviors via the activation of GABAA-ergic systems in rodents |
| Q33899789 | Protracted developmental trajectories of GABAA receptor alpha1 and alpha2 subunit expression in primate prefrontal cortex |
| Q34860798 | RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors |
| Q57573940 | Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study |
| Q38232547 | Re-examining the role of benzodiazepines in the treatment of schizophrenia: a systematic review |
| Q82733838 | Rebound increase in seizure susceptibility but not isolation-induced calls after single administration of clonazepam and Ro 19-8022 in infant rats |
| Q34354731 | Rebound potentiation of inhibition in juvenile visual cortex requires vision-induced BDNF expression |
| Q33927727 | Reduced GABAergic inhibition in the basolateral amygdala and the development of anxiety-like behaviors after mild traumatic brain injury. |
| Q27314540 | Reduced tonic inhibition after stroke promotes motor performance and epileptic seizures |
| Q37152448 | Role of inhibitory neurotransmission in the control of canine hypoglossal motoneuron activity in vivo |
| Q34241326 | Selective distribution of GABA(A) receptor subtypes in mouse spinal dorsal horn neurons and primary afferents |
| Q35171300 | Selective pyramidal cell reduction of GABA(A) receptor α1 subunit messenger RNA expression in schizophrenia |
| Q34510925 | Self-administration of bretazenil under progressive-ratio schedules: Behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines |
| Q34550714 | Sex dimorphism in seizure-controlling networks |
| Q46109640 | Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem |
| Q33315041 | Slow GABA(A) mediated synaptic transmission in rat visual cortex |
| Q43157530 | Specificity protein 4 (Sp4) transcriptionally regulates inhibitory GABAergic receptors in neurons |
| Q36838951 | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels |
| Q30498571 | Stress-hyperresponsive WKY rats demonstrate depressed dorsal raphe neuronal excitability and dysregulated CRF-mediated responses |
| Q34902898 | Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype |
| Q34440329 | Structure of genetic and environmental risk factors for dimensional representations of DSM-IV anxiety disorders |
| Q89185933 | Structure-Dependent Activity of Natural GABA(A) Receptor Modulators |
| Q30483976 | Studying Cerebellar Circuits by Remote Control of Selected Neuronal Types with GABA(A) Receptors |
| Q30435939 | Subunit-specific trafficking of GABA(A) receptors during status epilepticus |
| Q46058917 | The GABAergic system in the retina of neonate and adult Octodon degus, studied by immunohistochemistry and electroretinography. |
| Q42940716 | The Molecular Basis for Ca2+ Signalling by NAADP: Two-Pore Channels in a Complex? |
| Q35688528 | The TM2 6' position of GABA(A) receptors mediates alcohol inhibition |
| Q34554034 | The development of phasic and tonic inhibition in the rat visual cortex |
| Q36948429 | The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity. |
| Q33476818 | The sedating antidepressant trazodone impairs sleep-dependent cortical plasticity |
| Q41574564 | Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease |
| Q37839540 | Transcranial magnetic stimulation at the interface with other techniques: a powerful tool for studying the human cortex |
| Q37879217 | Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile |
| Q38038105 | Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders |
| Q30480900 | Traumatic brain injury and the effects of diazepam, diltiazem, and MK-801 on GABA-A receptor subunit expression in rat hippocampus |
| Q42281034 | Ubiquitin-proteasome dependent degradation of GABAAα1 in autism spectrum disorder |
| Q33945516 | Understanding the molecular diversity of GABAergic synapses. |
| Q34131906 | Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands - in vitro and in vivo characterization |
| Q41877109 | Wavelength-selective one- and two-photon uncaging of GABA. |
| Q61449922 | Zolpidem Activation of Alpha 1-Containing GABA Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons |
| Q51031520 | γ-Aminobutyric Acid Type A (GABAA) Receptor Subtype Inverse Agonists as Therapeutic Agents in Cognition |
| Q37065672 | γ-Aminobutyric Acid Type A (GABAA) Receptor Subunits Play a Direct Structural Role in Synaptic Contact Formation via Their N-terminal Extracellular Domains. |
Search more.